{"id":13913,"date":"2021-01-05T01:21:43","date_gmt":"2021-01-04T22:21:43","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/diyarbakir-ilinde-kronik-hepatit-b-hastalarinda-hepatit-a-seroprevalansi\/"},"modified":"2021-01-05T01:21:43","modified_gmt":"2021-01-04T22:21:43","slug":"diyarbakir-ilinde-kronik-hepatit-b-hastalarinda-hepatit-a-seroprevalansi","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/tr\/2021\/01\/05\/diyarbakir-ilinde-kronik-hepatit-b-hastalarinda-hepatit-a-seroprevalansi\/","title":{"rendered":"Diyarbak\u0131r \u0130linde Kronik Hepatit B Hastalar\u0131nda Hepatit A Seroprevalans\u0131"},"content":{"rendered":"<p><strong>Ama\u00e7<\/strong>: Hepatit A virusu (HAV) s\u0131k g\u00f6r\u00fclen akut viral hepatit etkenlerinden biri olup \u00f6zellikle eri\u015fkin ya\u015f grubunda akut karaci\u011fer yetmezli\u011fi gibi ciddi klinik tablolara yol a\u00e7abilmektedir. Rehberlerde kronik viral hepatit hasta grubunun HAV serolojilerinin de\u011ferlendirilmesi ve duyarl\u0131 bireylerin a\u015f\u0131lanmas\u0131 \u00f6nerilmektedir. Bu \u00e7al\u0131\u015fmada HBsAg pozitiflik oranlar\u0131n\u0131n \u00fclke ortalamas\u0131n\u0131n \u00fczerinde g\u00f6r\u00fcld\u00fc\u011f\u00fc Diyarbak\u0131r ilindeki Bismil Devlet Hastanesi\u2019nde takip edilen kronik hepatit B hastalar\u0131nda anti-HAV IgG seroprevalans\u0131n\u0131n belirlenmesi ama\u00e7land\u0131.<\/p>\n<p><strong>Y\u00f6ntemler<\/strong>: \u00c7al\u0131\u015fmaya 1 Ocak 2015 ve 31 Aral\u0131k 2016 tarihleri aras\u0131nda \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Poliklini\u011fi&#39;nde takibi yap\u0131lan 121 (%57.9)\u2019i erkek ve 88 (%42.1)\u2019i kad\u0131n olmak \u00fczere 209 kronik hepatit B hastas\u0131 dahil edildi. Makro-ELISA (Architect i2000 SR, Abbott, Abbott Park, IL, ABD) test kitleri kullan\u0131larak anti-HAV IgG ara\u015ft\u0131r\u0131lm\u0131\u015f olan hastalar\u0131n verileri retrospektif olarak de\u011ferlendirildi.<\/p>\n<p><strong>Bulgular<\/strong>: Toplamda anti-HAV IgG seroprevalans\u0131 %98.6 idi. Anti-HAV IgG seronegatifli\u011fi en y\u00fcksek oranda %11.8 ile 20 ya\u015f alt\u0131 grupta g\u00f6zlenmi\u015f olup bunu 20-29 ya\u015f grubu %1.6 oranla takip etti. 30 ya\u015f ve \u00fczeri grubun tamam\u0131nda anti-HAV IgG pozitifli\u011fi vard\u0131.<\/p>\n<p><strong>Sonu\u00e7lar<\/strong>: Kronik hepatit B tan\u0131l\u0131 eri\u015fkin hastalarda anti-HAV IgG pozitifli\u011fi y\u00fcksek oranda olmakla birlikte, \u00f6zellikle ad\u00f6lesan ve gen\u00e7 eri\u015fkinlerde HAV taramas\u0131n\u0131n yap\u0131lmas\u0131 ve duyarl\u0131 bireylerin a\u015f\u0131lanmas\u0131 gerekmektedir.<\/p>\n<p>Klimik Dergisi 2020; 33(1): 36-8.<\/p>\n<p><strong>Cite this article as<\/strong>: Bek\u00e7iba\u015f\u0131 M. [Hepatitis A seroprevalence in chronic hepatitis B patients in Diyarbakir, Turkey]. Klimik Derg. 2020; 33(1): 36-8. Turkish.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ama\u00e7: Hepatit A virusu (HAV) s\u0131k g\u00f6r\u00fclen akut viral hepatit etkenlerinden biri olup \u00f6zellikle eri\u015fkin ya\u015f grubunda akut karaci\u011fer yetmezli\u011fi gibi ciddi klinik tablolara yol a\u00e7abilmektedir. Rehberlerde kronik viral hepatit hasta grubunun HAV serolojilerinin de\u011ferlendirilmesi ve duyarl\u0131 bireylerin a\u015f\u0131lanmas\u0131 \u00f6nerilmektedir. Bu \u00e7al\u0131\u015fmada HBsAg pozitiflik oranlar\u0131n\u0131n \u00fclke ortalamas\u0131n\u0131n \u00fczerinde g\u00f6r\u00fcld\u00fc\u011f\u00fc Diyarbak\u0131r ilindeki Bismil Devlet Hastanesi\u2019nde takip [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5129],"tags":[5009,2937,5008],"class_list":["post-13913","post","type-post","status-publish","format-standard","hentry","category-ozgun-arastirma","tag-antihav-igg","tag-hepatit-a","tag-hepatit-b-yuzey-antijenleri"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts\/13913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/comments?post=13913"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/posts\/13913\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/media?parent=13913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/categories?post=13913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/tr\/wp-json\/wp\/v2\/tags?post=13913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}